HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Revco/Big B confidentiality agreement includes stay on poison pill suit.

This article was originally published in The Rose Sheet

Executive Summary

BIG B PUTS POISON PILL ON HOLD, ENTERS REVCO CONFIDENTIALITY AGREEMENT to provide Revco with confidential information pertaining to its proposed acquisition of Big B, Twinsburg, Ohio-based Revco announced Oct. 4. The agreement includes a stay on the litigation regarding Big B's "poison pill" shareholder rights plan that would activate when an acquiring company attempts to purchase 10% or more of Big B "without prior approval of the Big B board of directors."
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003311

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel